Subscribe To
Kalvista pharmaceuticals to present data on oral on-demand hae therapy kvd900 at aaaai 2022
CAMBRIDGE, Mass. & SALISBURY, England--(BUSINESS WIRE)---- $KALV--KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical compa...
February 2, 2022, 7:30 am
Enveric biosciences to participate in upcoming investor conferences in february 2022
NAPLES, Fla. , Jan. 27, 2022 /PRNewswire/ - Enveric Biosciences (NASDAQ: ENVB) ("Enveric" or the "Company"), a patient-centric biotechnology company...
January 27, 2022, 7:30 am
Enveric biosciences to participate in upcoming investor conferences in february 2022
NAPLES, Fla. , Jan. 27, 2022 /PRNewswire/ - Enveric Biosciences (NASDAQ: ENVB) ("Enveric" or the "Company"), a patient-centric biotechnology company...
January 27, 2022, 7:30 am
Enveric biosciences to participate in upcoming investor conferences in february 2022
NAPLES, Fla. , Jan. 27, 2022 /PRNewswire/ - Enveric Biosciences (NASDAQ: ENVB) ("Enveric" or the "Company"), a patient-centric biotechnology company...
January 27, 2022, 7:30 am
Why mainz biomed stock is crashing today
The molecular genetics diagnostic company announced the pricing of a follow-on stock offering....
January 26, 2022, 12:36 pm
Why mainz biomed stock is crashing today
The molecular genetics diagnostic company announced the pricing of a follow-on stock offering....
January 26, 2022, 12:36 pm
Why mainz biomed stock is crashing today
The molecular genetics diagnostic company announced the pricing of a follow-on stock offering....
January 26, 2022, 12:36 pm
Tango therapeutics' tng908 ind for cancer study gets green signal by fda
The FDA has cleared Tango Therapeutics Inc's (NASDAQ: TNGX) Investigational New Drug (IND) application for its lead program, TNG908. TNG908 is a sy...
January 24, 2022, 12:41 pm
Tango therapeutics' tng908 ind for cancer study gets green signal by fda
The FDA has cleared Tango Therapeutics Inc's (NASDAQ: TNGX) Investigational New Drug (IND) application for its lead program, TNG908. TNG908 is a sy...
January 24, 2022, 12:41 pm
Tango therapeutics' tng908 ind for cancer study gets green signal by fda
The FDA has cleared Tango Therapeutics Inc's (NASDAQ: TNGX) Investigational New Drug (IND) application for its lead program, TNG908. TNG908 is a sy...
January 24, 2022, 12:41 pm
Lantern pharma's lp-184 receives rare pediatric, orphan drug tags for rare form of cancer
The FDA has granted Rare Pediatric Disease and Orphan Drug Designations to Lantern Pharma Inc's (NASDAQ: LTRN) LP-184 for Atypical Teratoid Rhabdo...
January 24, 2022, 7:34 am
Lantern pharma's lp-184 receives rare pediatric, orphan drug tags for rare form of cancer
The FDA has granted Rare Pediatric Disease and Orphan Drug Designations to Lantern Pharma Inc's (NASDAQ: LTRN) LP-184 for Atypical Teratoid Rhabdo...
January 24, 2022, 7:34 am
Lantern pharma's lp-184 receives rare pediatric, orphan drug tags for rare form of cancer
The FDA has granted Rare Pediatric Disease and Orphan Drug Designations to Lantern Pharma Inc's (NASDAQ: LTRN) LP-184 for Atypical Teratoid Rhabdo...
January 24, 2022, 7:34 am
Novartis hopes to have another covid therapy on the way
Novartis and molecular Partners reported positive results for COVID-19 candidate ensovibep....
January 23, 2022, 2:28 am
Novartis hopes to have another covid therapy on the way
Novartis and molecular Partners reported positive results for COVID-19 candidate ensovibep....
January 23, 2022, 2:28 am
Novartis hopes to have another covid therapy on the way
Novartis and molecular Partners reported positive results for COVID-19 candidate ensovibep....
January 23, 2022, 2:28 am
Kaleido biosciences to present updated data of kb295 in ulcerative colitis at the 2022 crohn's and colitis congress
LEXINGTON, Mass., Jan. 21, 2022 (GLOBE NEWSWIRE) -- Kaleido Biosciences, Inc. (Nasdaq: KLDO), a clinical-stage biotech company with a differentiated, ...
January 21, 2022, 11:04 am
Kaleido biosciences to present updated data of kb295 in ulcerative colitis at the 2022 crohn's and colitis congress
LEXINGTON, Mass., Jan. 21, 2022 (GLOBE NEWSWIRE) -- Kaleido Biosciences, Inc. (Nasdaq: KLDO), a clinical-stage biotech company with a differentiated, ...
January 21, 2022, 11:04 am
Kaleido biosciences to present updated data of kb295 in ulcerative colitis at the 2022 crohn's and colitis congress
LEXINGTON, Mass., Jan. 21, 2022 (GLOBE NEWSWIRE) -- Kaleido Biosciences, Inc. (Nasdaq: KLDO), a clinical-stage biotech company with a differentiated, ...
January 21, 2022, 11:04 am
Fda clears turning point's ind for elzovantinib + aumolertinib combo regime in lung cancer setting
The FDA has signed off Turning Point Therapeutics Inc's (NASDAQ: TPTX) Investigational New Drug (IND) application for elzovantinib + au...
January 20, 2022, 10:36 am